Biopharmaceutical company Theranexus has announced that, together with the Centre de Recherche en Neurosciences de Lyon and CERMEP, it has been named winner of the Auvergne-Rhône-Alpes region's 'Pacte de recherche 2024' project.

Supported by funding of 320.000 from the Region, this project called IMASO is part of the continuation of the joint public/private laboratory 'Neuro-Imaging for drug Discovery (NI2D)' based in Lyon.

This joint laboratory was created at the end of 2020 and aims to strengthen Theranexus' capacity to characterize its drug candidates using new preclinical neuroimaging tools.

Copyright (c) 2024 CercleFinance.com. All rights reserved.